CXCL6 and cholangiocarcinoma: After collecting baseline peripheral blood from 26 CCA patients prior to immunotherapy (Table S3, Supporting Information), serum CXCL6 levels were measured by ELISA and showed that nonresponders tended to have higher serum concentrations of CXCL6 (Figure 6D).